Member Info for Laura2022

Moving up

They have moved it up

Jaari888

Go back to SCE which loses £10mln a year and is a going concern worry

Maybe another trade from here

Strategic Expansion of U.S. Uranium Portfolio

Initial Interest Acquired in New Mexico Uranium Venture with Option to Increase

Metals One Plc (AIM: MET1), a minerals exploration and development company, is pleased to announce that it has completed the acquisition of an initial 10% interest in NovaCore Exploration Inc. ("NovaCore"), a private U.S.-based company advancing the large-scale Red Basin Uranium Project in Catron County, New Mexico. The Company has also been granted warrants to increase its ownership to 30% on terms detailed below.

This strategic investment further supports Metals One's U.S. uranium expansion strategy, adding a third exploration-stage asset to the Company's growing portfolio, which includes the Squaw Creek (Wyoming) and Uravan (Colorado) Projects.

In the afternoon they were bidding for over 2mln yet maximum buy was just under £5000 , and real.spread was 0.46p to 0.479 ( then NT at 0.5p for £5k)

Clearly cannot see what the company is building and has won more contracts than 3 -3 other bio techs put together and whom are nowhere near breakeven revenues NOT with the client diversity, or new client wins nor with 3 -4 strings to the bow ( consultancy, bio statistic, personalised medicine, dosing software)

16th July - new contract with partner Numab

14th July - Trading statement

ahead of expectations for FY25. When compared to the year ended 30 June 2024 (FY24), these unaudited numbers would represent an increase in Total Income of approximately 46%

10th July : integration of PYC platform into global personalosed medical provoder DoseMeRx

1st July - new contract

16th June x 2 biostatistics contracts (first ones from new division)

29th May RNSPhysiomics Awarded Contract Extension

9th May RNSContract Award with New UK Client

17th Apr Physiomics Awarded New Contract

16th Apr RNS-R Publication of Peer Reviewed Article

15th Apr new contract

17th Mar RNS Contract Award with new client

Are basically the company saying "the share price should not be down here " and everything is on track and now with grant funding more than the entire market valuation of GENF

I have been patient

I've been watching the block selling (often grey trades ).from weeks noq

Eg last week there had been about 15mln grey trades sells and this week even more

WCAP also had Miton selling, so had TIR

Miton and maybe one other seller are now out of GENF

I'll be adding more to the £10,000 bought yesterday

Why 20 posts on PYC but in same time none on SCE?

Rooster

Main brokers are best way ( IG III HL) as opposed to the online new comers

On iii it was giving qoutes to buy 1mln but not 2mln

Thanks phevs and Trench

Yes, from yesterday, suggests the 1mth+ overhang may be over

Large delayed trade

Added another £3000

In that case

This could be Miton last 1.5mln

17-Jul-2512:31:010.5651,500,000

0.47p £4800

0.5 NT £5000

2phevs

Can't recall one but Google

"Physiomics contract congenica" maybe?

Increasing to 0.48p ( all 0 47p+ buys last 2 days ) and now NT £5k

Looks set

1st lots

Tje

SHAREHOLDER ORDINARY SHARES % AFTER

ERIC LEIRE 124,414,999 27.4%

JONATHAN MARK SWANN 21,025,000 4.6%

ADRIAN BEESTON 17,475,000 3.9%

PREMIER MITON 15,147,262 3.3%

SAMANTHA BAUER 14,500,000 3.2%